2022
DOI: 10.3390/genes13122377
|View full text |Cite
|
Sign up to set email alerts
|

Dual Molecular Diagnoses of Recessive Disorders in a Child from Consanguineous Parents: Case Report and Literature Review

Abstract: The widespread use of whole exome sequencing (WES) resulted in the discovery of multilocus pathogenic variations (MPV), defined as two or more distinct or overlapping Mendelian disorders occurring in a patient, leading to a blended phenotype. In this study, we report on a child with autosomal recessive primary microcephaly-5 (MCPH5) and nephropathic cystinosis. The proband is the first child of consanguineous parents, presenting a complex phenotype including neurodevelopmental delay, microcephaly, growth restr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 54 publications
0
1
0
Order By: Relevance
“…The concept of multilocus pathogenic variations (MPV) is relatively new, corresponding to the occurrence of two or more monogenic disorders in the same individual, which leads to complex phenotypes difficult to identify only by clinical or biochemical tests ( Baltaci et al, 2021 ; Correia-Costa et al, 2022 ; Herman et al, 2022 ). Since the advent of genome/exome sequencing, MPVs have been identified in 1.4% to 7.2% of patients with rare diseases ( Yang et al, 2013 , 2014 ; Posey et al, 2017 ; Correia-Costa et al , 2022 ). For autosomal recessive disorders, homozygous MPVs can reach up to 29% of patients in populations that present high rates of consanguineous marriage ( Mitani et al, 2021 ).…”
mentioning
confidence: 99%
“…The concept of multilocus pathogenic variations (MPV) is relatively new, corresponding to the occurrence of two or more monogenic disorders in the same individual, which leads to complex phenotypes difficult to identify only by clinical or biochemical tests ( Baltaci et al, 2021 ; Correia-Costa et al, 2022 ; Herman et al, 2022 ). Since the advent of genome/exome sequencing, MPVs have been identified in 1.4% to 7.2% of patients with rare diseases ( Yang et al, 2013 , 2014 ; Posey et al, 2017 ; Correia-Costa et al , 2022 ). For autosomal recessive disorders, homozygous MPVs can reach up to 29% of patients in populations that present high rates of consanguineous marriage ( Mitani et al, 2021 ).…”
mentioning
confidence: 99%